MА №16 2014 Pulmonology
3. Severe asthma
AV Emelyanov, GR Sergeeva, EV Leshenkova, Department of Pulmonology, North-Western
State Medical University named after I.I. Mechnikov, St. Petersburg
References
1. Rabe KF, Adachi M, Lai CKW et al. Worldwide severity and control of asthma in children
and adults: the global Asthma Insights and Reality surveys. J Allergy Clin Immunol, 2004,
114: 40-47.
2. Bousquet J, Mantzouranis E, Cruz AA et al. Uniform definition of asthma severity, control,
and exacerbations: Document presented for the World Health Organization Consultation on
Severe Asthma. J Allergy Clin Immunol, 2010, 126: 926-38.
3. Chung KF, Wenzel SE, Brozek JL et al. International ERS/ATS guidelines on definition,
evaluation and treatment of severe asthma. Eur Respir J, 2014, 43: 343-373.
4. Trevor JL, Deshane JS. Refractory asthma: mechanisms, targets, and therapy. Allergy, 2014,
69: 217-227.
5. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA
cross-sectional European multicentre study of the clinical phenotype of chronic severe
asthma. Eur Respir J, 2003, 22: 470-477.
6. Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, Weiss S, Zheng B,
Johnson C, Wenzel S. Design and baseline characteristics of The Epidemiology and Natural
history of asthma: Outcomes and treatment Regimens (TENOR) study: a large cohort of
patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004, 92: 32–
39.
7. Moore W, Bleecker ER, Curran-Everett D et al. Characterization of the severe asthma
phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research
Program. J Allergy Clin Immunol 2007,119: 405-13.
8. Jarjour NN, Erzurum SC, Eugene R. Bleecker ER et al. Severe Asthma Lessons Learned
from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J
Respir Crit Care Med 2012, 185, 356–362.
9. Fedoseyev GB, Emelyanov AV, Sergeeva GR. Prevalence of asthma and allergic rhinitis in
adults in St. Petersburg. Therapeutic Archives, 2003, 75 ( 1): 23-26.
10. Djukanovich R, Wison S, Kraft M et al. Effect of treatment with anti-immunoglobulin E
antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care
Med, 2004,170: 583-593.
11. Global Initiative for asthma. Global Strategy for Asthma Management and Prevention.
Revised 2014, www.ginasthma.org.
12. Bousquet J, Cabrer P, Berkman N et al. The effect of treatment with omalizumab, an anti-IgE
antibody, on asthma exacerbations and emergency medical visits in patients with severe
persistent asthma. Allergy 2005, 60: 302-308.
13. Humber M, Beasley R, Ayres J et al. Benefits of omalizumab as add-on therapy in patients
with severe persistent asthma who are inadequately controlled despite best available therapy
(GINA 2002 step 4 treatment): INNOVATE. Allergy 2005, 60: 309-316.
14. Sullivan S.D., Turk F. An evaluation of the cost-effectiveness of omalizumab for the
treatment of severe allergic asthma. Allergy, 2008, 63: 670-684.
15. Kolbin AS. Pharmacoeconomic assessment of feasibility of omalizumab in patients with
persistent atopic moderate to severe asthma. Pharmacoeconomic Studies. 2 Bronchopulmonology, 2013: 53-66.
16. Korn S, Thielen A, Seyfried S et al. Omalizumab in patients with severe persistent allergic
asthma in real life setting in Germany. Respir Med 2009, 103: 1725-1731.
17. Cox L, Platts-Mills TAE, Finegold I et al. American Academy of Allergy, Asthma &
Immunology/American College of Allergy, Asthma and Immunology Joint Task Force
Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol.
18. Corren J, Lemanske RF, Hanania NA. Lebrikizumab in treatment of adults with asthma. N
Engl J Med, 2011, 365: 1088-1098.
19. Wenzel S, Ford L, MD, Pearlman D et al. Dupilumab in Persistent Asthma with Elevated
Eosinophil Levels. N Eng J Med, 2013, 368(26): 2455-2466.
20. Pavord ID, Korn S, Bleeker ER et al. Mepolizumab for severe eosinophilic asthma
(DREAM): a multicenter, double-blind, placebo-controlled trial. Lancet 2012, 380 (9842):
651-659.
21. Brusselle GG, VanderStichele C, Jordens P et al. Azithromycin for prevention of
exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebocontrolled trial. Thorax 2013, 68: 322-329.
22. Kerstjens HAM, Engel M, Dahl R et al. Tiotropium in asthma poorly controlled with
standard combination therapy. N Engl J Med 2012, 367(13): 1198-1207.
23. Wechsler ME1, Laviolette M, Rubin AS et al. Bronchial thermoplasty: Long-term safety and
effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol, 2013, 132(6):
1295-1302.
24. Torrego A, Solar I, Minoz AM et al. Bronchial thermoplasty for moderate or severe
persistent asthma in adults. Cochrane Database Syst Rev, 2014, Mar 3, 3: CD009910.

IPF RTP as of Sep 10, 2014.xlsx

2014 Scholarship Winners - Portage Community School District

ALN Roster - JDAI Helpdesk

Chapter 4